N
Nathan Ford
Researcher at World Health Organization
Publications - 476
Citations - 25127
Nathan Ford is an academic researcher from World Health Organization. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 82, co-authored 455 publications receiving 21982 citations. Previous affiliations of Nathan Ford include Imperial College London & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Drug development for neglected diseases: a deficient market and a public-health policy failure
Patrice Trouiller,Piero Olliaro,Piero Olliaro,Els Torreele,James Orbinski,James Orbinski,Richard Laing,Richard Laing,Nathan Ford +8 more
TL;DR: It is found that, of 1393 new chemical entities marketed between 1975 and 1999, only 16 were for tropical diseases and tuberculosis, and there is a 13-fold greater chance of a drug being brought to market for central-nervous-system disorders or cancer than for a neglected disease.
Journal ArticleDOI
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.
Laurent Ferradini,Arnaud Jeannin,Loretxu Pinoges,Jacques Izopet,Didakus Odhiambo,Limangeni Mankhambo,Gloria Karungi,Elisabeth Szumilin,Serge Balandine,Gaëlle Fedida,M. Patrizia Carrieri,Bruno Spire,Nathan Ford,Jean-Michel Tassie,Philippe J Guerin,Christopher Brasher +15 more
TL;DR: These data show that large numbers of people can rapidly benefit from antiretroviral therapy in rural resource-poor settings and strongly supports the implementation of such large-scale simplified programmes in Africa.
Journal ArticleDOI
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
Haileyesus Getahun,Alberto Matteelli,Ibrahim Abubakar,Mohamed Abdel Aziz,Annabel Baddeley,Draurio Barreira,Saskia Den Boon,Susana Marta Borroto Gutierrez,Judith Bruchfeld,Erlina Burhan,Solange Cavalcante,Rolando Cedillos,Richard E. Chaisson,Cynthia B.E. Chee,Lucy Chesire,Elizabeth L. Corbett,Masoud Dara,Justin T Denholm,Gerard De Vries,Dennis Falzon,Nathan Ford,Margaret Gale-Rowe,Chris Gilpin,Enrico Girardi,Un Yeong Go,Darshini Govindasamy,Alison D. Grant,Malgorzata Grzemska,Ross J Harris,C. Robert Horsburgh,Asker Ismayilov,Ernesto Jaramillo,Sandra V. Kik,Katharina Kranzer,Christian Lienhardt,Philip A. LoBue,Knut Lönnroth,Guy B. Marks,Dick Menzies,Giovanni Battista Migliori,Davide Mosca,Ya Diul Mukadi,Alwyn Mwinga,Lisa J. Nelson,Nobuyuki Nishikiori,Anouk M. Oordt-Speets,Molebogeng Xheedha Rangaka,Andreas Reis,Lisa D. Rotz,Andreas Sandgren,Monica Sañé Schepisi,Holger J. Schünemann,Surender Kumar Sharma,Giovanni Sotgiu,Helen R. Stagg,Timothy R. Sterling,Tamara Tayeb,Mukund Uplekar,Marieke J. van der Werf,Wim Vandevelde,Femke van Kessel,Anna H. van’t Hoog,Jay K. Varma,Natalia Vezhnina,Constantia Voniatis,Marije Vonk Noordegraaf-Schouten,Diana Weil,Karin Weyer,Robert J. Wilkinson,Takashi Yoshiyama,Jean-Pierre Zellweger,Mario C. Raviglione +71 more
TL;DR: The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation and patients with silicosis.
Journal ArticleDOI
Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda
Edward J Mills,Celestin Bakanda,Josephine Birungi,Keith Chan,Nathan Ford,Curtis Cooper,Jean B. Nachega,Mark Dybul,Robert S. Hogg +8 more
TL;DR: Ugandan patients receiving cART can expect an almost normal life expectancy, although there is considerable variability among subgroups of patients.
Journal ArticleDOI
Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.
TL;DR: This review suggests a combination of interventions to retain specific groups at risk for attrition such as workplace programmes for employed patients, dedicated clinic and support programmes for men and younger individuals.